These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20842399)

  • 1. Neurophysiological correlates of cognitive disturbances in multiple sclerosis.
    Leocani L; Gonzalez-Rosa JJ; Comi G
    Neurol Sci; 2010 Nov; 31(Suppl 2):S249-53. PubMed ID: 20842399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment and neurophysiological correlates in MS.
    Magnano I; Aiello I; Piras MR
    J Neurol Sci; 2006 Jun; 245(1-2):117-22. PubMed ID: 16697015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurophysiological investigations in multiple sclerosis.
    Leocani L; Comi G
    Curr Opin Neurol; 2000 Jun; 13(3):255-61. PubMed ID: 10871248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurophysiological imaging techniques in dementia.
    Comi G; Leocani L
    Ital J Neurol Sci; 1999; 20(5 Suppl):S265-9. PubMed ID: 10662966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Event-related potential P300 in multiple sclerosis. Relation to magnetic resonance imaging and cognitive impairment.
    Honig LS; Ramsay RE; Sheremata WA
    Arch Neurol; 1992 Jan; 49(1):44-50. PubMed ID: 1728263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment in multiple sclerosis.
    Jongen PJ; Ter Horst AT; Brands AM
    Minerva Med; 2012 Apr; 103(2):73-96. PubMed ID: 22513513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis.
    López-Góngora M; Escartín A; Martínez-Horta S; Fernández-Bobadilla R; Querol L; Romero S; Mañanas MÀ; Riba J
    PLoS One; 2015; 10(8):e0136786. PubMed ID: 26322632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of disease modifying treatments on cognitive dysfunction in multiple sclerosis.
    Comi G
    Neurol Sci; 2010 Nov; 31(Suppl 2):S261-4. PubMed ID: 20967477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive event-related potentials in multiple sclerosis: Correlation with MRI and neuropsychological findings.
    Kimiskidis VK; Papaliagkas V; Sotirakoglou K; Kouvatsou ZK; Kapina VK; Papadaki E; Tsimourtou V; Masoura E; Kazis DA; Papayiannopoulos S; Geroukis T; Bostanjopoulou S
    Mult Scler Relat Disord; 2016 Nov; 10():192-197. PubMed ID: 27919489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Movement preparation is affected by tissue damage in multiple sclerosis: evidence from EEG event-related desynchronization.
    Leocani L; Rovaris M; Martinelli-Boneschi F; Annovazzi P; Filippi M; Colombo B; Martinelli V; Comi G
    Clin Neurophysiol; 2005 Jul; 116(7):1515-9. PubMed ID: 15953556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive deficits in multiple sclerosis: a review of functional MRI studies.
    Caramia F; Tinelli E; Francia A; Pozzilli C
    Neurol Sci; 2010 Nov; 31(Suppl 2):S239-43. PubMed ID: 20694492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurophysiological and cognitive markers of disease evolution in multiple sclerosis.
    Comi G; Martinelli V; Locatelli T; Leocani L; Medaglini S
    Mult Scler; 1998 Jun; 4(3):260-5. PubMed ID: 9762686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment in early stages of multiple sclerosis.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Hakiki B; Giannini M; Pastò L; Razzolini L
    Neurol Sci; 2010 Nov; 31(Suppl 2):S211-4. PubMed ID: 20640466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroencephalographic coherence analysis in multiple sclerosis: correlation with clinical, neuropsychological, and MRI findings.
    Leocani L; Locatelli T; Martinelli V; Rovaris M; Falautano M; Filippi M; Magnani G; Comi G
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):192-8. PubMed ID: 10896692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment in multiple sclerosis.
    Chiaravalloti ND; DeLuca J
    Lancet Neurol; 2008 Dec; 7(12):1139-51. PubMed ID: 19007738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options of cognitive impairment in multiple sclerosis.
    Patti F; Leone C; D'Amico E
    Neurol Sci; 2010 Nov; 31(Suppl 2):S265-9. PubMed ID: 20953811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of cognitive evoked potentials for detecting early cognitive disorders in multiple sclerosis].
    Magnié MN; Bensa C; Laloux L; Bertogliati C; Faure S; Lebrun C
    Rev Neurol (Paris); 2007 Nov; 163(11):1065-74. PubMed ID: 18033045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI and cognition in multiple sclerosis.
    Filippi M; Rocca MA
    Neurol Sci; 2010 Nov; 31(Suppl 2):S231-4. PubMed ID: 20635114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evoked potentials in monitoring multiple sclerosis.
    Leocani L; Medaglini S; Comi G
    Neurol Sci; 2000; 21(4 Suppl 2):S889-91. PubMed ID: 11205369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mismatch negativity (MMN) in multiple sclerosis: an event-related potentials study in 46 patients.
    Jung J; Morlet D; Mercier B; Confavreux C; Fischer C
    Clin Neurophysiol; 2006 Jan; 117(1):85-93. PubMed ID: 16325469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.